A modified anticancer drug can simultaneously target tumor sites and show whether or not it is working
Cancer drugs can be modified to specifically target tumor sites to help personalize cancer treatment. And while it is relatively easy to determine if the drugs have been delivered to the correct location, it is more difficult to monitor their therapeutic success. Now, a team led by Bin Liu from the A*A*STAR Institute of Materials Research and Engineering in Singapore, in collaboration with Ben Zhong Tang at Hong Kong University of Science and Technology, has developed an anticancer drug with an inbuilt mechanism that shows if it is working1.
Platinum-based drugs are effective against many cancers, killing cells by triggering cellular suicide, or apoptosis. These drugs can, however, have severe side effects. Nontoxic forms can be modified, as a type of prodrug, to convert to their toxic form only after entering the targeted tumor cells, so as not to harm noncancerous cells.
Liu and colleagues went one step further by modifying a platinum-based prodrug to not only target tumor cells effectively, but also show whether or not it was having the desired effect. According to Liu, this added feature could be crucial for improving cancer treatment.
“Early evaluation of a patient’s response to a specific cancer therapy is important in clinical applications because it can minimize the duration of ineffective courses,” explains Liu. “The effectiveness of cancer treatment is commonly evaluated using magnetic resonance imaging to measure the tumor size, but this is unsatisfactory as the change in size is not obvious at the early stages of therapy.”
In their new system, Liu and her team included an apoptosis sensor that is released when the prodrug converts to its toxic form inside the targeted tumor cells. The toxic form triggers cell apoptosis and activates an enzyme called caspase 3, which then cleaves the apoptosis sensor and causes it to fluoresce green. This provides a visual signal that the drug is killing the cells.
The Latest on: Anticancer drug
via Google News
The Latest on: Anticancer drug
- Tapping Into an Ancient Evolutionary Survival Mechanism: Cancer Cells Hibernate Like Bears to Evade Harsh Chemotherapyon January 23, 2021 at 7:47 am
Tapping into an ancient evolutionary survival mechanism, cancer cells enter into a sluggish, slow-dividing state to survive the harsh environment created by chemotherapy or other targeted agents. In ...
- Chemotherapy Induced Anemia Drug Market Size 2021 by Research Methodology, Value Chain Analysis, Distributors and Forecast to 2025on January 22, 2021 at 9:02 am
Jan (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Anemia is a common complication in ...
- New drug target valid for breast cancer as well as lymphomaon January 21, 2021 at 5:40 pm
One more piece of the puzzle has fallen into place behind a new drug whose anti-cancer potential was developed at the University of Alberta and is set to begin human trials this year, thanks to newly ...
- New tool developed at UBC Okanagan removes chemotherapy drugs from water systemson January 21, 2021 at 11:14 am
It is especially pertinent to the challenges facing University of British Columbia (UBC) researchers who are investigating methods to remove chemicals and pharmaceuticals from public water systems.
- Pre-surgery chemotherapy is possible for early stage pancreatic cancer patientson January 21, 2021 at 8:03 am
A first-of-its-kind randomized clinical trial found that patients with pancreatic cancer didn't live any longer than expected after receiving pre-operative chemotherapy from either of the two standard ...
- Drug-delivery microcapsules tagged with zirconium-89 can be tracked by PET imagingon January 20, 2021 at 4:00 pm
Polymer and radionuclide chemists report major advance in microcapsule drug delivery systems. Their microcapsules -- labeled with radioactive zirconium-89 -- are the first example of hollow polymer ...
- Anticancer Drugs Market Major Key Players: F.Hoffmann-La Roche Ltd, Novartis AG, Eli Lily and Companyon January 19, 2021 at 8:44 pm
Advanced cancer technologies are making inroads into the anticancer drugs market for the diagnosis and treatment of cancer with minimal invasion. Patients are showing high interest towards advanced ...
- New tool removes chemotherapy drugs from water systemson January 19, 2021 at 10:23 am
What goes in, must come out' is a familiar refrain. It is especially pertinent to the challenges facing UBC researchers who are investigating methods to remove chemicals and pharmaceuticals from ...
- Single-cell test can reveal precisely how drugs kill cancer cellson January 19, 2021 at 9:23 am
Cancer cells are smart when it comes to anti-cancer drugs, evolving and becoming resistant to even the strongest chemotherapies over time. To combat this evasive behavior, researchers have developed a ...
- Boryung revs up anti-cancer drug production line at Yesan planton January 18, 2021 at 11:07 pm
Boryung Pharmaceutical announced it had begun full-fledged use of its Yesan plant and more emphasis on anti-cancer products. Boryung announced Tuesday that it had been producing plasma cell myeloma ...
via Bing News